Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
Details for Australian Patent Application No. 2007268081 (hide)
International Classifications
Event Publications
8 January 2009 PCT application entered the National Phase
PCT publication WO2007/139729 Priority application(s): WO2007/139729
26 February 2009 Assignment before Grant
Methylgene Inc.; Merck & Co., Inc. The application has been assigned to Methylgene Inc.
23 April 2009 Alteration of Name
The name of the applicant has been altered to MethylGene Inc.
19 May 2011 Assignment before Grant
MethylGene Inc. The application has been assigned to MethylGene Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007268083-Pyrazolo [1, 5-A] pyrimidines as CDK inhibitors
2007268075-Chemically modified oligonucleotide primers for nucleic acid amplification
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser